Table 1. The clinical and pathological parameters analysis of CDCP1 in cervical cancer.
| Clinicopathological variable | Total (N=176) | Low expression | High expression | P value |
| Age/years | 92 | 84 | ||
| ≤42 | 67 | 33 | 34 | |
| >42 | 109 | 59 | 50 | 0.5296 |
| FIGO stage | ||||
| Ia2 | 5 | 3 | 2 | |
| Ib1 | 40 | 24 | 16 | |
| Ib2 | 53 | 31 | 22 | |
| Ib3 | 17 | 7 | 10 | |
| IIa1 | 17 | 11 | 6 | |
| IIa2 | 7 | 4 | 3 | |
| IIB | 3 | 2 | 1 | |
| IIIC | 34 | 10 | 24 | 0.1083 |
| Tumor size | ||||
| ≤4 | 135 | 77 | 58 | |
| >4 | 41 | 15 | 26 | 0.02166 |
| Pathological types | ||||
| Squamous cell carcinoma | 152 | 79 | 73 | |
| Adenocarcinoma | 16 | 9 | 7 | |
| Adenosquamous carcinoma | 8 | 4 | 4 | 0.9438 |
| Stromal invasion | ||||
| <1/2 | 68 | 33 | 35 | |
| ≥1/2 | 108 | 59 | 49 | 0.4302 |
| Lymphovascular space invasion | ||||
| Yes | 24 | 13 | 11 | |
| No | 152 | 79 | 73 | 0.8416 |
| Differentiation grade | ||||
| Well | 16 | 10 | 6 | |
| Moderate | 41 | 20 | 21 | |
| Poor | 119 | 62 | 57 | 0.6464 |
| Pelvic lymph node metastasis | ||||
| Yes | 34 | 10 | 24 | |
| No | 142 | 82 | 60 | 0.002967 |
| Vaginal invasion | ||||
| Yes | 27 | 17 | 10 | |
| No | 149 | 75 | 74 | 0.2268 |
| Parametrial infiltration | ||||
| Yes | 3 | 2 | 1 | |
| No | 173 | 90 | 83 | 1 |
| Reccurrence | ||||
| Yes | 14 | 2 | 12 | |
| No | 162 | 90 | 72 | 0.003017 |
| Vital status at follow-up | ||||
| Alive | 160 | 88 | 72 | |
| Dead | 16 | 4 | 12 | 0.02198 |
Significance was determined using Chi-squared test. Bold text indicates P< 0.05 and results are statistically significant.